Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) dropped 2% during mid-day trading on Monday . The company traded as low as $0.50 and last traded at $0.50. Approximately 1,080 shares changed hands during trading, an increase of 513% from the average daily volume of 176 shares. The stock had previously closed at $0.51.
Mosaic ImmunoEngineering Price Performance
The firm’s fifty day moving average is $0.54 and its 200-day moving average is $0.57. The stock has a market capitalization of $3.62 million, a price-to-earnings ratio of -5.55 and a beta of -0.78.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.
Further Reading
- Five stocks we like better than Mosaic ImmunoEngineering
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
